TYR and Alzheimer disease: Within the plasma ATN biomarkers, there was no difference in terms of Plasma‐A among each group (p > 0.05, Figure 1D), and plasma p‐tau181 (Plasma‐T) was higher in participants classified as AD and MCI compared to those determined as CN (p < 0.001, Figure 1E).